Johannesburg, 18 April 2017 – Cryo-Save South Africa, a leading private stem cell bank, has been granted AABB accreditation for its South African laboratory, based in Pretoria. With no public stem cell bank in Africa, the Cryo-Save laboratory provides access to private stem cell processing and storage services in Southern Africa.
Cryo-Save South Africa, which is part of JSE-listed Financial Services Group, Ecsponent Limited, is responsible for the collection, processing and storage of umbilical cord blood stem cells for both Cryo-Save and Salveo Biotechnology. The facility now joins similar facilities in the United States and around the world who have also earned AABB Accreditation.
AABB, formerly known as the American Association of Blood Banks, is an international non-profit association, representing individuals and institutions involved in the field of transfusion medicine and cellular therapies. Accreditation by the association follows an intensive on-site assessment by specially trained assessors who established that the level of technical and administrative performance within the facility meets or exceeds the standards set by the Association.
AABB’s Accreditation Programme (recognised by the International Society for Quality in Healthcare – ISQua) contributes to quality and safety of collection, processing, testing, distributing and administration of stem cells.
Erna West, Head of Product Development at Ecsponent Biotechnology notes that, since inception, the Cryo-Save South Africa laboratory has always operated under the internationally governed policies, processes and procedures of its parent company in Europe.
“This international accreditation now adds an extra layer of confidence for both parents, who store their babies’ stem cells at the Cryo-Save laboratory, and for healthcare professionals, who collect the umbilical cord blood and tissue at the birth.”
“The AABB Accreditation procedures are voluntary,” Dr Robert Crookes, Medical Director of Cryo-Save South Africa explained. “Cryo-Save South Africa has sought AABB accreditation as this programme assists facilities around the world in achieving excellence by promoting a level of professional and technical expertise that contributes to quality performance and patient safety.”
“With the advancements in biotechnology, and the fact that stem cells have been used to treat over 80 different diseases including leukaemia and other blood-related diseases, more and more expecting parents are considering umbilical cord stem cell storage. We will continue to uphold these standards as we remain focused on our mission to advance the health of South Africans, by providing access to affordable, life-saving technologies to everyone who wants to make responsible and informed choices for their children,” adds West.
Since 2000, Cryo-Save and Salveo have stored over 310,000 umbilical cord blood stem cell collections both locally and in Europe.
Established in 1947, AABB (formally known as the American Association of Blood Banks) is an international, not-for-profit association dedicated to the advancements of science and practice of transfusion medicine and related biological therapies. The association is committed to improving health by developing and delivering standards, accreditation and educational programmes and services to optimise patient and donor care and safety.
Cryo-Save is an international group of family stem cell banks, licensed to collect, analyse, process, cryopreserve, store and release umbilical cord blood and cord tissue stem cells. With more than 310,000 samples stored worldwide, Cryo-Save is a leading and technologically advanced stem cell bank in Europe. With no public stem cell bank in Africa, the Cryo-Save laboratory provides access to private stem cell processing and storage services in Southern Africa.
Established in 2000, the Cryo-Save Group has been active in the stem cell industry for more than 15 years. Its long-established professionalism and expertise is recognised by the medical community and samples from over 30 countries have been cryopreserved in processing and storage facilities in Belgium, Dubai, South Africa and Switzerland.
In 2009, Cryo-Save became the first lab in the world to offer a validated cord tissue stem cell storage service and further extended their offering in 2013 to provide unique viability testing on cord tissue.
Cryo-Save South Africa is owned by two publicly listed companies, providing unmatched financial security for your investment. The Cryo-Save laboratory is jointly owned by JSE-listed Ecsponent Limited (JSE:ECS) and Esperite N.V. listed on the Amsterdam stock exchange (AMS:ESP).
Ecsponent is an African Financial Services company, established in 1998. Esperite is a leading international group of companies, including Cryo-Save and Salveo Swiss Biotechnology (Geneva-based leader in predictive medicine) amongst other entities, active in the fields of stem cell preservation, genetic analysis, predictive medicine, informative diagnostic tests, and consultancy.
By combining these futuristic technologies with the Ecsponent Group’s local financial expertise, South Africans have access to the leading health investment choices of the future, including cellular therapies as well as research in Southern Africa. These investments today, give parents peace of mind about their children’s health and future, and could even save lives.
For more information on Cryo-Save or stem cell storage contact 087 8080 170 or email@example.com.